FLEXIBZUMAB

Welcome to the Brand page for “FLEXIBZUMAB”, which is offered here for Pharmaceutical preparations, a drug delivery system comprising monoclonal antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (copd), the forgoing containing monoclonal antibodies; monoclonal antibodies for medical and veterinary purposes; monoclonal antibody preparations for therapeutic purposes; monoclonal antibodies for targeting drugs to calcified tissue for therapeutic purposes;.

Its status is currently believed to be active. Its class is unavailable. “FLEXIBZUMAB” is believed to be currently owned by “Elastrin Therapeutics Inc.”